Agenda 

Section One -       Guest presentation

Title:     mHealth China: Designing a Winning Business Model

Speaker:  Dr James Xiao, Senior Manager, Pharmaceutical and Life Sciences, PwC China

1. mHealth global report – executive summary

Ÿ   This report assesses the market opportunities and challenges for mHealth from the perspective of patients, payers, and providers

2. mHealth China report – executive summary

Ÿ   Analyze mHealth’s current status in China

Ÿ   Establish guiding principles of designing new mHealth businesses

Ÿ   Illustrate through case studies of new mHealth businesses

3. mHealth China report key findings

Ÿ   Expanding mobile users and increasing healthcare needs collide to form a fertile ground for mHealth experiments

Ÿ   A framework of analyzing mHealth user needs

Ÿ   New services will be designed with deep user insight on mHealth’s primary users: consumers and physicians

Ÿ   Many existing mHealth models in China are incremental improvement along incumbents’ product expansion

Ÿ   Promising mHealth models align stakeholders with quantifiable benefits to generate sustainable revenue

Ÿ   A supporting environment could accelerate mHealth growth in China

Section Two -       Working Group Internal Discussion

Experts from different product scopes exchange ideas

Focus of this time - Standardization

Section Three - Any other business

Speakers

Dr. James Xiao

Senior Manager, Pharmaceutical & Life Sciences, PwC China

Dr. James Xiao

Senior Manager, Pharmaceutical & Life Sciences, PwC China

View speaker details

Dr. James Xiao is a Senior Manager in PwC’s Advisory in Shanghai. He focuses on pharmaceutical, biotech and medical devices sectors. He has over 10 years of experiences in health and pharmaceutical industries, advising global companies in growth and investment strategy, sales and marketing, and operation improvement.
Before joining PwC’s Shanghai office, Dr. Xiao worked at PwC’s Chicago office under similar industry focus and responsibilities. Before joining PwC globally, Dr. Xiao worked as a global business development executive for pharma companies and as a health economist in the U.S. Dr. Xiao was a New Investigator Award recipient from ISPOR for his research on healthcare costs and intervention programs.
Dr. James Xiao has a MBA from Northwestern University’s Kellogg School of Management, a Ph.D. in Economics from Florida International University and a Bachelor of Economics from Renmin University.

Contact